fC6MQX

Annual Scientific Meeting Agenda – Wednesday, October 2266. An Assessment of Gastric and Small Bowel PressureProfiles in Diabetics With Gastroparesis Before and During 28Days of Treatment With the Motilin Receptor Agonist Camicinal(GSK962040)Kenneth Barshop, MD, George Dukes, MD, Matthew Barton, MD,Jack Semler, MD, Braden Kuo, MD, University of Chicago PritzkerSchool of Medicine, Chicago, IL, Massachusetts General Hospital,Boston, MA, GlaxoSmithKline, Raleigh, NC67. Gastric Electric Stimulation: A Prospective Analysis of 151Patients at a Single CenterJason Heckert, BS, Sean Harbison, MD, Henry P. Parkman, MD,FACG, Temple University, Philadelphia, PA68. Colorectal Cancer Patients Have Higher Rates of AdvancedFeatures in Their Diminutive Adenomas Compared to PatientsUndergoing Average-Risk Screening2014 ACG Colorectal Cancer Prevention AwardAmoah Yeboah-Korang, MD, MPH, MSc, Philip Vutien, MD, KateriEvans, MS, Michael Greenspan, MD, Sohrab Mobarhan, MD,Shriram Jakate, MD, Joshua Melson, MD, MPH, Rush UniversityMedical Center, Chicago, IL69. Insertion Water Exchange Minimizes EndoscopistMultitasking During Withdrawal Inspection: A PlausibleExplanation for Enhanced Polyp Detection in the Right ColonAndrew Yen, MD, FACG, Victoria Y. Yung, MD, Joseph W. Leung,MD, MACG, Surinder Mann, MD, FACG, Machelle D. Wilson,PhD, Felix W. Leung, MD, FACG, Sacramento VA Medical Center,VANCHCS, Mather, CA, University of California, Davis MedicalCenter, Sacramento, CA, Sepulveda Ambulatory Care Center,VAGLAHS, North Hills, CA70. Comparing Diagnostic Tests in Dyssynergic Defecation-ConstipationDanse Bi, MD, Sandra Sostrich, MD, Mojtaba Olyaee, MD, ElenaSidorenko, MD, Tuba Esfandyari, MD, University of Kansas MedicalCenter, Kansas City, KS71. Clostridium difficile Associated Risk of Death Score(CARDS): A Novel Risk Score to Predict Mortality AmongHospitalized Patients With Clostridium difficile Infection2014 ACG Fellow AwardZain Kassam, MD, MPH, Camila Cribb Fabersunne, MD, MPHCandidate, Mark B. Smith, MD, PhD Candidate, Gilaad G. Kaplan,MD, MPH, Geoffrey C. Nguyen, MD, PhD, Ashwin N. Ananthakrishnan,MBBS, MPH, Massachusetts Institute of Technology,Cambridge, MA, Harvard Medical School, Boston, MA, Universityof Calgary, Calgary, Alberta, Canada, University of Toronto, Toronto,Ontario, Canada, Massachusetts General Hospital, Boston, MA72. Fresh, Frozen, or Lyophilized Fecal Microbiota Transplantation(FMT) for Multiple Recurrent C. difficile Infection (CDI)Zhi-Dong Jiang, PhD, Nadim J. Ajami, PhD, Todd Lasco, PhD,Joe Petrosino, PhD, Fredric Hochman, MD, Victor Ankoma-Sey,MD, Matthew Wong, PhD, Ashley Alexander, MS, Shi Ke, MS,Herbert L. DuPont, MD, University of Texas SPH, Houston, TX,Baylor College of Medicine, Houston, TX, Baylor St. Luke’s MedicalCenter, Houston, TX10:15 am – 10:45 am David Y. Graham Lecture(Terrace Ballroom 3)Idiosyncratic Drug-Induced Liver Injury:What Have We Learned in the LastDecade?Naga P. Chalasani, MD, FACGAssess recent developments in the diagnosisand management of DILI.Introduced by:Harry E. Sarles, Jr., MD, FACGACG PresidentSee page 4 for more information.10:45 am – 11:00 am Break11:00 am – 12:15 pm Simultaneous Symposia 5simultaneous symposia 5a: The Inpatient HepatologyConsultmoderator: Mark W. Russo, MD, MPH, FACGFluid, Distention, Infection, Oh My: Approach to the PatientWith AscitesMark W. Russo, MD, MPH, FACGTreat patients with massive ascites and spontaneous bacterialperitonitis.Water, Water Everywhere: Approach to the Cirrhotic Patient WithAcute Kidney InjuryJasmohan S. Bajaj, MD, FACGEvaluate the cirrhotic patient with acute kidney injury, including hepatorenalsyndrome, acute kidney injury and hyponatremia.A Rational Guide to the Use of TIPSAtif Zaman, MD, FACGDiscuss appropriate indications for TIPS referrals and manage post-TIPScomplications.simultaneous symposia 5b: The Human Microbiomemoderator: Eamonn M. M. Quigley, MD, FACGHuman Intestinal Microbiome: What the PracticingGastroenterologist Should KnowEamonn M. M. Quigley, MD, FACGIdentify how the microbiome functions and interacts within the GItract.What Is the Evidence that the Intestinal Microbiome Has a Role inGastrointestinal Diseases?Lawrence J. Brandt, MD, MACGDefine the role of the human microbiome in relation to GI disorders.Targeting the Intestine Microbiota in the Treatment ofGastrointestinal DiseasesYehuda Ringel, MD, FACGAssess the role of the human microbiome in the treatment of GI diseases.12:15 pm ANNUAL SCIENTIFIC MEETING ADJOURNSFor more information on ACG 2014 and to register, visit www.acgmeetings.gi.org.36